Clinical Trials

64 enrolled 20 charts

Adenocarcinoma, Gastrointestinal Neoplasms, Neoplasm Metastasis

NCT03997968 2024-12-24

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckLymphoidPlasma cellSarcomaThoracic

169 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Lymphoma, Mantle-Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02861300 2024-12-19

CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer

50 enrolled 16 charts

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Rectal Neoplasms, Colorectal Neoplasms

NCT04276493 2024-12-06

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

71 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT03852251 2024-08-02

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma

338 enrolled

Diabetes Mellitus, Insulin-Dependent, 12

NCT02024009 2024-07-25

SCALOP-2

159 enrolled

Pancreatic Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

73 enrolled 18 charts

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03853707 2024-02-20

Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer

28 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT02024607 2023-11-15

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer

495 enrolled 18 charts

Advanced Gastrointestinal Cancer

NCT02324543 2023-07-21

Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

47 enrolled 22 charts

Metastatic Pancreatic Adenocarcinoma

NCT03770689 2023-03-21

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

19 enrolled 21 charts

Locally Advanced Rectal Cancer

NCT00193128 2021-11-24

Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer

59 enrolled 8 charts

Esophageal Neoplasms

NCT02393755 2021-07-08

Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

42 enrolled 16 charts

Colonic Neoplasms, Rectal Neoplasms

NCT01077986 2021-04-21

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

35 enrolled

Pancreatic Neoplasms

NCT00121251 2021-04-06

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

17 enrolled 13 charts

Genitourinary

Carcinoma, Renal Cell

NCT01323530 2021-01-11

A Confirmation Study of Eribulin in Combination With Capecitabine

76 enrolled 24 charts

Breast Neoplasms

NCT01193517 2020-04-15

Azacitidine and CAPOX in Metastatic Colorectal Cancer

26 enrolled 12 charts

Colorectal Neoplasms

NCT00565370 2020-01-18

Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP

22 enrolled 11 charts

Stomach Neoplasms

NCT00634751 2019-11-26

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

48 enrolled 13 charts

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT02773459 2019-09-30

MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer

31 enrolled

Biliary Tract Neoplasms

NCT00004187 2019-06-26

Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00869570 2019-05-15

External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer

54 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT01326481 2019-03-18

TRC105

19 enrolled 9 charts

Breast Neoplasms

NCT00438256 2019-01-23

Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

50 enrolled 7 charts

Pancreatic Neoplasms

NCT01661972 2018-10-29

X-TRAP

63 enrolled 12 charts

Neoplasm Metastasis, Colorectal Neoplasms

NCT00741260 2018-09-05

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

105 enrolled 19 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01975454 2018-04-19

Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer

62 enrolled

Colorectal Neoplasms

NCT01730222 2017-09-01

PACT-19

137 enrolled

Disease, Pancreatic Neoplasms

NCT00327743 2016-05-18

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

34 enrolled

Breast Neoplasms, Neoplasms

NCT00468585 2016-01-22

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

62 enrolled 9 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01099527 2015-12-29

A Trial of RAD001/Capecitabine in Refractory Gastric Cancer

59 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT00578071 2015-07-02

POXX

29 enrolled 10 charts

Esophageal Neoplasms

NCT01525771 2015-06-29

XPID

37 enrolled

Stage IV Gastric Cancer With Metastasis

NCT00070252 2015-05-04

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

53 enrolled

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00719550 2013-12-05

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

130 enrolled

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT00086931 2013-03-08

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

37 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00784446 2013-01-07

First-line Therapy of Stage IV Colorectal Cancer

51 enrolled

Colorectal Neoplasms

NCT00037609 2012-10-24

Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00217711 2012-06-05

Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

23 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003902 2012-05-15

Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement

110 enrolled

Breast Neoplasms

NCT00031876 2012-05-15

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

34 enrolled

Breast Neoplasms

NCT00021047 2012-03-08

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00006108 2012-02-07

Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Breast Neoplasms

NCT01016639 2011-10-17

CORGI

106 enrolled

Gallbladder Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00345761 2010-08-16

Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer

64 enrolled

Colorectal Neoplasms

NCT00744640 2010-01-12

GEMOXEL

46 enrolled

Pancreatic Neoplasms

NCT00242788 2009-04-23

IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure

40 enrolled

Colorectal Neoplasms

NCT00350961 2008-08-26

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

39 enrolled

Cholangiocarcinoma

NCT00076609 2007-03-28

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

31 enrolled